Leading integrated radiotherapy systems maker Varian Medical (VAR) has secured the approval of the U.S. Food and Drug Administration (FDA) for its novel Proton Therapy System, which delivers protons ...
Flash ultra-high dose rate therapy enabled by Varian proton and planning technologies Collaboration between Varian and leading institutions drives progress toward next-generation cancer treatments ...
Radiation oncology is a field in remarkable transformation: a deepening global shortage of trained practitioners, persistent inequities in access to treatment – and, on the other side of the ledger, a ...
The "United States Proton Therapy Market Report Forecast by Indication. States and Company Analysis 2025-2033" report has been added to ResearchAndMarkets.com's offering. United States Proton Therapy ...
Ensuring the proper identification and positioning of a patient during radiation treatment is essential. Now, proton therapy player Varian Medical Systems Inc. has acquired Munich, Germany-based ...
Medtronic plc expects its Hugo robotic-assisted surgery system to be a key growth driver, especially when it receives U.S. FDA approval. Already approved for use ...
In the article that accompanies this editorial, Howard et al 1 provide a state of the union summary regarding the status of proton therapy in the United States. Proton therapy is a rapidly growing ...
LifeScienceIndustryResearch.com adds United States and Japan - Proton Therapy Market, Patients & Forecast market research of 75 pages, to the Pharmaceuticals ...
The MarketWatch News Department was not involved in the creation of this content. -- Flash ultra-high dose rate therapy enabled by Varian proton and planning technologies -- Collaboration between ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results